Artemisinin

青蒿素

Report date: 2022/02/21 13:46:00
NME

Base Information

Drug NameArtemisinin
Drug Alias Name黄蒿素ArtemisineArteannuinartemisininumartemisinina +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADH-ubiquinone oxidoreductase chain 4 modulators
TargetsNADH-ubiquinone oxidoreductase chain 4
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsMalaria
Global Approved IndicationsMalaria
Approved Indications in ChinaMalaria
Original Approved Country/TerritoryMainland China
Original Approved Date1991/01/01
Country/TerritorySaudi ArabiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesKpc Pharmaceuticals Inc
Inactive CompaniesPrincess Nourah Bint Abdulrahman University
Active IndicationsMalaria
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections

Other Information

ATC CodeP01BE01
Related LinksWikipediaKEGG